Lobe Sciences Ltd (LOBE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | N/A | N/A | 180 | N/A | N/A |
| Accounts receivable | 4 | 175 | -12 | -31 | -56 |
| Other Working Capital | 67 | 363 | 140 | 283 | 332 |
| Other Operating Activity | -865 | -1,197 | -1,150 | -1,188 | -1,949 |
| Operating Cash Flow | $-795 | $-659 | $-842 | $-936 | $-1,674 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | -59 | N/A | N/A |
| Sale Of Investment | N/A | 961 | N/A | N/A | N/A |
| Other Investing Activity | 479 | 0 | -309 | 0 | 0 |
| Investing Cash Flow | $479 | $961 | $-368 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | 0 | 0 | -44 |
| Common Stock Issued | 0 | 0 | 0 | 106 | 3,383 |
| Other Financing Activity | 0 | 0 | 25 | -72 | 0 |
| Financing Cash Flow | $0 | $0 | $25 | $33 | $3,340 |
| Exchange Rate Effect | 0 | 0 | 2 | -5 | 25 |
| Beginning Cash Position | 1,444 | 1,142 | 2,325 | 1,798 | 107 |
| End Cash Position | 1,128 | 1,444 | 1,142 | 2,325 | 1,798 |
| Net Cash Flow | $-316 | $302 | $-1,185 | $532 | $1,666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -795 | -659 | -842 | -936 | -1,674 |
| Free Cash Flow | -795 | -659 | -842 | -936 | -1,674 |